FLOW CYTOMETRY, CD 16+56

The Flow Cytometry CD16+56 Test is a specialized immunophenotyping assay used to identify and quantify Natural Killer (NK) cells, a critical component of the body's innate immune system. The test uses advanced flow cytometry technology to analyze cells expressing the surface markers CD16 and CD56, which are characteristic markers of NK cells.

Natural Killer cells play an essential role in immune defense by identifying and destroying virus-infected cells, abnormal cells, and certain cancer cells without requiring prior sensitization. They are an important part of the body's first-line immune response and contribute to immune surveillance against infections and malignancies.

Flow cytometry allows rapid and accurate measurement of NK cell populations in blood or other specimens. The test is frequently performed as part of lymphocyte subset analysis, immune system evaluation, immunodeficiency investigations, and hematological assessments.

Benefits of the Test

• Measures Natural Killer (NK) cell populations
• Evaluates immune system function
• Assists in diagnosing immune deficiencies
• Supports hematological and immunological assessments
• Helps monitor immune-related disorders
• Provides valuable information for clinical management

Why Doctors Recommend This Test

Doctors may recommend Flow Cytometry CD16+56 testing for:

• Immune deficiency evaluation
• Recurrent infections
• Lymphocyte subset analysis
• Hematological malignancy assessment
• Monitoring immune system disorders
• Autoimmune disease evaluation
• Post-transplant immune monitoring
• Investigation of abnormal immune responses

The test is often performed alongside other lymphocyte markers such as CD3, CD4, CD8, CD19, and CD45.

Preparation Before Test

The test typically requires a blood sample.

• No fasting is generally required
• Inform your doctor about current medications
• Follow laboratory-specific instructions if provided
• Maintain normal hydration before testing

A routine venous blood sample is collected for analysis.

Normal Reporting Time

Results are generally available within 1 to 3 working days, depending on laboratory workflow and panel complexity.

Who Should Take This Test?

• Patients with recurrent infections
• Individuals with suspected immune deficiencies
• Patients undergoing lymphocyte subset analysis
• Individuals with autoimmune disorders
• Hematology and oncology patients
• Organ transplant recipients requiring immune monitoring

The Flow Cytometry CD16+56 Test provides important information about NK cell populations and overall immune system status.

Clinical Significance

CD16 and CD56 are commonly expressed on:

• Natural Killer (NK) cells
• Certain NK-like T-cell populations

Abnormal NK cell counts may be associated with:

• Primary immunodeficiency disorders
• Secondary immune deficiencies
• Viral infections
• Autoimmune diseases
• Hematological malignancies
• Post-transplant immune status changes

The results are interpreted together with other lymphocyte subset markers and clinical findings to provide a comprehensive assessment of immune function.

Important Note

CD16+56 testing is usually performed as part of a comprehensive immunophenotyping panel. Results should always be interpreted by an immunologist, hematologist, or treating physician in conjunction with other laboratory findings and clinical history.